{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:42:57Z","timestamp":1790962977716,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404961"],"award-info":[{"award-number":["82404961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["226-2024-00001"],"award-info":[{"award-number":["226-2024-00001"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Visceral leishmaniasis (VL) is the most lethal form of leishmaniasis. In terms of anti-leishmanial vaccines, favorable immune responses are Th1 responses that primarily produce interferon gamma (IFN-\u03b3) and activate macrophages for leishmanicidal effects. The selection of IFN-\u03b3-inducing epitopes in silico may reduce the steps of pre-clinical evaluation and increase the certainty of the better-designed vaccine. <jats:italic>Wolbachia<\/jats:italic> surface protein (WSP) derived from <jats:italic>Wolbachia<\/jats:italic> bacteria that have been reported to reside in sandflies can trigger TLR2 and TLR4 activation to favor Th1 immune responses, which may serve as a potential adjuvant candidate for the <jats:italic>Leishmania<\/jats:italic> vaccine. Therefore, in this study, helper T lymphocyte epitopes that may induce favorable immune responses were identified, and WSP was served as an adjuvant to design a novel multi-epitope vaccine candidate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>\n              <jats:italic>Leishmania<\/jats:italic> hemoglobin receptor (HbR), kinetoplastid membrane protein-11 (KMP-11), glycoprotein of 63\u00a0kDa (Gp63), thiol-specific antioxidant antigen (TSA), and sterol 24-c-methyltransferase (SMT) were analyzed by immunoinformatics to screen helper T lymphocyte and cytotoxic T lymphocyte epitopes. The antigenicity, toxicity, allergenicity, and IFN-\u03b3-inducing epitope potential of T epitopes were predicted. The immune simulation was performed to calculate IFN-\u03b3\/interleukin (IL)-10 ratios to predict the immune responses induced by the helper T lymphocyte epitopes. Molecular docking and molecular dynamics simulations were carried out to analyze the interactions and stability of the docked complexes. The immune simulation of a multi-epitope vaccine candidate was carried out to predict its immunogenicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Some helper T lymphocyte epitopes that were predicted with the potential of inducing Th1 responses and cytotoxic T lymphocyte epitopes were selected to develop a novel multi-epitope vaccine candidate with WSP as an adjuvant. It was found in molecular docking and interaction analysis that TLR2 and TLR4 can recognize WSP, supporting the potential of adjuvant for the <jats:italic>Leishmania<\/jats:italic> vaccine. The results from immune simulation demonstrated that the multi-epitope vaccine candidate induced obvious cytokine (IFN-\u03b3, IL-12, and IL-2) secretion and Th1 as well as memory T cell production, similar to that of Leish-111f.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our vaccine candidate may interact with TLR2 and TLR4 and exhibit good immunogenicity, favoring <jats:italic>Leishmania<\/jats:italic> clearance. Our strategy provides a novel multi-epitope vaccine candidate and references for other vaccine developments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13071-025-06756-5","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:13:05Z","timestamp":1742947985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening helper T lymphocyte epitopes based on IFN-\u03b3\/IL-10 ratio for developing a novel multi-epitope vaccine candidate using Wolbachia surface protein as an adjuvant against visceral leishmaniasis"],"prefix":"10.1186","volume":"18","author":[{"given":"Jianhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoyan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjian","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"6756_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392:951\u201370.","journal-title":"Lancet"},{"key":"6756_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.pt.2017.06.004","volume":"33","author":"L Solano-Gallego","year":"2017","unstructured":"Solano-Gallego L, Cardoso L, Pennisi MG, Petersen C, Bourdeau P, Oliva G, et\u00a0al. Diagnostic challenges in the era of canine Leishmania infantum vaccines. Trends Parasitol. 2017;33:706\u201317.","journal-title":"Trends Parasitol"},{"key":"6756_CR3","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","volume":"34","author":"PM Gillespie","year":"2016","unstructured":"Gillespie PM, Beaumier CM, Strych U, Hayward T, Hotez PJ, Bottazzi ME. Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016;34:2992\u20135.","journal-title":"Vaccine"},{"key":"6756_CR4","doi-asserted-by":"publisher","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","volume":"31","author":"J Alvar","year":"2013","unstructured":"Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Case study for a vaccine against leishmaniasis. Vaccine. 2013;31:B244-249.","journal-title":"Vaccine"},{"key":"6756_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","volume":"162","author":"CM Beaumier","year":"2013","unstructured":"Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME. New vaccines for neglected parasitic diseases and dengue. Transl Res. 2013;162:144\u201355.","journal-title":"Transl Res"},{"key":"6756_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/C5SC03892H","volume":"7","author":"M Skwarczynski","year":"2016","unstructured":"Skwarczynski M, Toth I. Peptide-based synthetic vaccines. Chem Sci. 2016;7:842\u201354.","journal-title":"Chem Sci"},{"key":"6756_CR7","doi-asserted-by":"publisher","first-page":"234ra256","DOI":"10.1126\/scitranslmed.3008222","volume":"6","author":"S Das","year":"2014","unstructured":"Das S, Freier A, Boussoffara T, Das S, Oswald D, Losch FO, et\u00a0al. Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med. 2014;6:234ra256.","journal-title":"Sci Transl Med"},{"key":"6756_CR8","doi-asserted-by":"publisher","first-page":"202ra121","DOI":"10.1126\/scitranslmed.3006406","volume":"5","author":"R Guha","year":"2013","unstructured":"Guha R, Gupta D, Rastogi R, Vikram R, Krishnamurthy G, Bimal S, et\u00a0al. Vaccination with Leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis. Sci Transl Med. 2013;5:202ra121.","journal-title":"Sci Transl Med"},{"key":"6756_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Shankar P, Mishra J, Singh S. Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors. 2016;9:277.","journal-title":"Parasit Vectors"},{"key":"6756_CR10","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","volume":"29","author":"J Chakravarty","year":"2011","unstructured":"Chakravarty J, Kumar S, Trivedi S, Rai VK, Singh A, Ashman JA, et\u00a0al. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine. 2011;29:3531\u20137.","journal-title":"Vaccine"},{"key":"6756_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fimmu.2015.00524","volume":"6","author":"SC de Mendon\u00e7a","year":"2015","unstructured":"de Mendon\u00e7a SC, Cysne-Finkelstein L, Matos DC. Kinetoplastid Membrane protein-11 as a vaccine candidate and a virulence factor in Leishmania. Front Immunol. 2015;6:524.","journal-title":"Front Immunol"},{"key":"6756_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230381","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, He J, Li J, Zhou Q, Chen H, Zheng Z, et\u00a0al. The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis. PLoS ONE. 2020;15:e0230381.","journal-title":"PLoS ONE"},{"key":"6756_CR13","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","volume":"37","author":"S Ratnapriya","year":"2019","unstructured":"Ratnapriya S, Sahasrabuddhe AA, Dube A. Visceral leishmaniasis: an overview of vaccine adjuvants and their applications. Vaccine. 2019;37:3505\u201319.","journal-title":"Vaccine"},{"key":"6756_CR14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/14760584.2021.1990043","volume":"20","author":"PM Kaye","year":"2021","unstructured":"Kaye PM, Mohan S, Mantel C, Malhame M, Revill P, Le Rutte E, et\u00a0al. Overcoming roadblocks in the development of vaccines for leishmaniasis. Expert Rev Vaccines. 2021;20:1419\u201330.","journal-title":"Expert Rev Vaccines"},{"key":"6756_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010609","volume":"16","author":"F Karimian","year":"2022","unstructured":"Karimian F, Koosha M, Choubdar N, Oshaghi MA. Comparative analysis of the gut microbiota of sand fly vectors of zoonotic visceral leishmaniasis (ZVL) in Iran; host-environment interplay shapes diversity. PLoS Negl Trop Dis. 2022;16:e0010609.","journal-title":"PLoS Negl Trop Dis"},{"key":"6756_CR16","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1126\/science.1068732","volume":"295","author":"A Saint Andr\u00e9","year":"2002","unstructured":"Saint Andr\u00e9 A, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, Volkmann L, et\u00a0al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science. 2002;295:1892\u20135.","journal-title":"Science"},{"key":"6756_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4049\/jimmunol.173.1.437","volume":"173","author":"NW Brattig","year":"2004","unstructured":"Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, B\u00fcttner DW, Ceciliani F, et\u00a0al. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol. 2004;173:437\u201345.","journal-title":"J Immunol"},{"key":"6756_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fimmu.2019.01144","volume":"10","author":"S Kumar","year":"2019","unstructured":"Kumar S, Sunagar R, Gosselin E. Bacterial protein toll-like-receptor agonists: a novel perspective on vaccine adjuvants. Front Immunol. 2019;10:1144.","journal-title":"Front Immunol"},{"key":"6756_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/imm.12364","volume":"144","author":"M Pathak","year":"2015","unstructured":"Pathak M, Verma M, Srivastava M, Misra-Bhattacharya S. Wolbachia endosymbiont of Brugia malayi elicits a T helper type 17-mediated pro-inflammatory immune response through Wolbachia surface protein. Immunology. 2015;144:231\u201344.","journal-title":"Immunology"},{"key":"6756_CR20","doi-asserted-by":"publisher","first-page":"310ra167","DOI":"10.1126\/scitranslmed.aac5477","volume":"7","author":"Z Mou","year":"2015","unstructured":"Mou Z, Li J, Boussoffara T, Kishi H, Hamana H, Ezzati P, et\u00a0al. Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells. Sci Transl Med. 2015;7:310ra167.","journal-title":"Sci Transl Med"},{"key":"6756_CR21","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","volume":"20","author":"YA Skeiky","year":"2002","unstructured":"Skeiky YA, Coler RN, Brannon M, Stromberg E, Greeson K, Crane RT, et\u00a0al. Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant. Vaccine. 2002;20:3292\u2013303.","journal-title":"Vaccine"},{"key":"6756_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","volume":"63","author":"J Greenbaum","year":"2011","unstructured":"Greenbaum J, Sidney J, Chung J, Brander C, Peters B, Sette A. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics. 2011;63:325\u201335.","journal-title":"Immunogenetics"},{"key":"6756_CR23","first-page":"531","volume":"112","author":"MR Wilkins","year":"1999","unstructured":"Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, et\u00a0al. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol. 1999;112:531\u201352.","journal-title":"Methods Mol Biol"},{"key":"6756_CR24","doi-asserted-by":"publisher","first-page":"128753","DOI":"10.1016\/j.ijbiomac.2023.128753","volume":"258","author":"T Dhanushkumar","year":"2024","unstructured":"Dhanushkumar T, Selvam PK, Santhosh ME, Vasudevan K, George Priya Doss C, Zayed H, et\u00a0al. Rational design of a multivalent vaccine targeting arthropod-borne viruses using reverse vaccinology strategies. Int J Biol Macromol. 2024;258:128753.","journal-title":"Int J Biol Macromol"},{"key":"6756_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ijbiomac.2018.08.125","volume":"120","author":"B Vakili","year":"2018","unstructured":"Vakili B, Eslami M, Hatam GR, Zare B, Erfani N, Nezafat N, et\u00a0al. Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum. Int J Biol Macromol. 2018;120:1127\u201339.","journal-title":"Int J Biol Macromol"},{"key":"6756_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc. 2010;5:725\u201338.","journal-title":"Nat Protoc"},{"key":"6756_CR27","doi-asserted-by":"publisher","first-page":"W384","DOI":"10.1093\/nar\/gkt458","volume":"41","author":"L Heo","year":"2013","unstructured":"Heo L, Park H, Seok C. GalaxyRefine: protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 2013;41:W384-388.","journal-title":"Nucleic Acids Res"},{"key":"6756_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et\u00a0al. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12:255\u201378.","journal-title":"Nat Protoc"},{"key":"6756_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.902066","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li J, Hu K, Zhou Q, Chen X, He J, et\u00a0al. Screening novel vaccine candidates for Leishmania\u00a0donovani by combining differential proteomics and immunoinformatics analysis. Front Immunol. 2022;13:902066.","journal-title":"Front Immunol"},{"key":"6756_CR30","doi-asserted-by":"publisher","first-page":"1259612","DOI":"10.3389\/fimmu.2023.1259612","volume":"14","author":"S Aiman","year":"2023","unstructured":"Aiman S, Ahmad A, Khan AA, Alanazi AM, Samad A, Ali SL, et\u00a0al. Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica - a hierarchical subtractive proteomics and immunoinformatics approach. Front Immunol. 2023;14:1259612.","journal-title":"Front Immunol"},{"key":"6756_CR31","doi-asserted-by":"publisher","first-page":"1269774","DOI":"10.3389\/fimmu.2023.1269774","volume":"14","author":"QR Jyotisha","year":"2023","unstructured":"Jyotisha QR, Qureshi IA. Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches. Front Immunol. 2023;14:1269774.","journal-title":"Front Immunol"},{"key":"6756_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS ONE. 2010;5:e9862.","journal-title":"PLoS ONE"},{"key":"6756_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.128071","volume":"254","author":"L Yuan","year":"2024","unstructured":"Yuan L, Li X, Li M, Bi R, Li Y, Song J, et\u00a0al. In silico design of a broad-spectrum multiepitope vaccine against influenza virus. Int J Biol Macromol. 2024;254:128071.","journal-title":"Int J Biol Macromol"},{"key":"6756_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/356083a0","volume":"356","author":"R L\u00fcthy","year":"1992","unstructured":"L\u00fcthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 1992;356:83\u20135.","journal-title":"Nature"},{"key":"6756_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12916-023-02750-9","volume":"21","author":"R Alam","year":"2023","unstructured":"Alam R, Samad A, Ahammad F, Nur SM, Alsaiari AA, Imon RR, et\u00a0al. In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever. BMC Med. 2023;21:36.","journal-title":"BMC Med"},{"key":"6756_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri3803","volume":"15","author":"S Crotty","year":"2015","unstructured":"Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015;15:185\u20139.","journal-title":"Nat Rev Immunol"},{"key":"6756_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCRESAHA.122.321116","volume":"131","author":"P Roy","year":"2022","unstructured":"Roy P, Sidney J, Lindestam Arlehamn CS, Phillips E, Mallal S, Armstrong Suthahar SS, et\u00a0al. Immunodominant MHC-II (major histocompatibility complex II) restricted epitopes in human apolipoprotein B. Circ Res. 2022;131:258\u201376.","journal-title":"Circ Res"},{"key":"6756_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuad004","author":"SJ Goodswen","year":"2023","unstructured":"Goodswen SJ, Kennedy PJ, Ellis JT. A guide to current methodology and usage of reverse vaccinology towards in silico vaccine discovery. FEMS Microbiol Rev. 2023; 47(2): fuad004.","journal-title":"FEMS Microbiol Rev"},{"key":"6756_CR39","doi-asserted-by":"publisher","first-page":"1192385","DOI":"10.3389\/fimmu.2023.1192385","volume":"14","author":"D Hu","year":"2023","unstructured":"Hu D, Irving AT. Massively-multiplexed epitope mapping techniques for viral antigen discovery. Front Immunol. 2023;14:1192385.","journal-title":"Front Immunol"},{"key":"6756_CR40","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCULATIONAHA.119.042863","volume":"142","author":"D Wolf","year":"2020","unstructured":"Wolf D, Gerhardt T, Winkels H, Michel NA, Pramod AB, Ghosheh Y, et\u00a0al. Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B (100)-reactive CD4(+) T-regulatory cells. Circulation. 2020;142:1279\u201393.","journal-title":"Circulation"},{"key":"6756_CR41","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3389\/fimmu.2020.01784","volume":"11","author":"R Dong","year":"2020","unstructured":"Dong R, Chu Z, Yu F, Zha Y. Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches. Front Immunol. 2020;11:1784.","journal-title":"Front Immunol"},{"key":"6756_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","volume":"9","author":"P Kaye","year":"2011","unstructured":"Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol. 2011;9:604\u201315.","journal-title":"Nat Rev Microbiol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06756-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06756-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06756-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:56:29Z","timestamp":1743256589000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06756-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6756"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06756-5","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. We did not perform any experiments that needed ethical approval and consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}